Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT

Conditions: Ocular Graft-versus-host Disease Interventions: Drug: Cyclosporine ophthalmic solution 0.1%; Drug: Tacrolimus ophthalmic ointment 0.03% Sponsors: Hospital Universitario Dr. Jose E. Gonzalez Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials